Creating a seamless experience for HCPs across all your channels will ensure greater engagement with your brand. Enabling them to find the information they want in a format they prefer should be a key part of your omnichannel strategy. However, it’s important to remember that the HCP demographic is changing, and with that so should the method of delivering content. So how do we ensure that we serve up content that both engages the HCP and adds value for pharma?
Wednesday, July 27, 2022 | 11AM ET / 8AM PT / 4PM UK. Experts from Tangent90, Veeva Systems and Compas, Inc. will discuss why ePrints are an important part of your customer engagement strategy.
As we slowly move on from the pandemic, we are seeing a return to in-person events. Our own research shows that 100% of the 65 medical congresses we have surveyed are providing in-person events, with 40% of those providing a hybrid solution. So how does the industry manage this dual approach? And how can we ensure we keep both audiences engaged?
What have we learned from the last two years? We can share information, maintain HCP relationships, and drive acquisition, all via the click of a button. The world has well and truly embraced a digital-first approach but how do we ensure that we don’t overwhelm HCPs, simply because the method of communication is easier?
In Pharmaceutical Commerce magazine, Tangent90 CEO Jan van den Burg discusses the value that HCPs place on scientific content and highlights the opportunity that pharma should be taking now.
Veeva recently published an eBook which discusses the best practice approach for supporting emerging pharma to launch and scale content faster. It focuses on how digital communications have allowed field teams to spend more quality time with HCPs. What can pharma’s brand teams do to support the increase needed?
We have been inundated with discussions about big data. Information that can help inform decision making is an output of nearly every phase in life sciences. The industry, with the increased use of digital channels, has been able to collect more data but is this being used to optimise their HCP engagement strategies?
The use of digital communications comes with new challenges when compared to the traditional paper era. Whilst virtual events and online publications and documents are nothing new, the increased reliance on them is, and there is a danger that digital fatigue could set in if the content is not tailored to the user.
The more information you have, the better informed you are. Data offers the ability to tailor and personalise the customer experience. But are we doing enough and what opportunities are there to optimise HCP engagement?
With demand for in-person, fully virtual and hybrid events high and expected to remain so, the hybrid approach needs to ensure it can cater for the different audience requirements, whilst at the same time, continuing to deliver quality information.
Tangent90 Ltd, a leading technology company that enables pharma to overcome the challenges of sharing scientific digital content with healthcare professionals, welcome the appointment of John Robson as Account Director.
A recent article on PharmExec.com by Paul Shawah, Executive Vice President of Commercial Strategy at Veeva Systems, highlighted the opportunity COVID has presented for pharma to accelerate digital transformation.
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.